1. Home
  2. BMY
  3. BMY News

Latest Bristol-Myers Squibb Company (BMY) News on February 22, 2025

Prothena Q4 Earnings Miss Estimates, Pipeline Progress in Focus
BMY

Zacks

a day ago

Prothena Q4 Earnings Miss Estimates, Pipeline Progress in Focus

BMY

Argus Research

2 days ago

Daily – Vickers Top Buyers & Sellers for 02/20/2025

BMY

Clinical Trials Arena

2 days ago

BMS’ Opdivo plus chemotherapy shows OS benefit in Phase III NSCLC study

Bristol Myers Cancer Drug Opdivo In Combination With Chemo Shows Improved Overall Survival In Certain Patients With Lung Cancer
BMY

Benzinga

3 days ago

Bristol Myers Cancer Drug Opdivo In Combination With Chemo Shows Improved Overall Survival In Certain Patients With Lung Cancer

BMY

MT Newswires

3 days ago

Amneal Pharmaceuticals Launching Mesalamine, Gets US FDA Approval for Lenalidomide

BMY

MT Newswires

3 days ago

Bristol-Myers Squibb's Lung Cancer Drug Shows Significant Increase in Patients' Overall Survival

Bristol Myers Squibb Announces Opdivo® Plus Chemotherapy as the First and Only Neoadjuvant-Only Immuno-Oncology Therapy to Demonstrate Statistically Significant and Clinically Meaningful Overall Survival in Resectable Non-Small Cell Lung Cancer
BMY

Business Wire

3 days ago

Bristol Myers Squibb Announces Opdivo® Plus Chemotherapy as the First and Only Neoadjuvant-Only Immuno-Oncology Therapy to Demonstrate Statistically Significant and Clinically Meaningful Overall Survival in Resectable Non-Small Cell Lung Cancer

Bristol Myers announces new five-year results from POETYK PSO trial
BMY

TipRanks

4 days ago

Bristol Myers announces new five-year results from POETYK PSO trial

BMY

MT Newswires

4 days ago

Redburn Atlantic Adjusts Price Target on Bristol-Myers Squibb to $54 From $52, Maintains Neutral Rating

Bristol Myers Squibb’s Sotyktu shows consistent safety profile in psoriasis trial
BMY

Clinical Trials Arena

5 days ago

Bristol Myers Squibb’s Sotyktu shows consistent safety profile in psoriasis trial

Why Bristol-Myers Squibb (BMY) Is Among the Best Drug Stocks to Buy Now
BMY

Insider Monkey

5 days ago

Why Bristol-Myers Squibb (BMY) Is Among the Best Drug Stocks to Buy Now

New Five-Year Sotyktu (deucravacitinib) Data Show Consistent Safety and Durable Response Rates in Moderate-to-Severe Plaque Psoriasis
BMY

Business Wire

6 days ago

New Five-Year Sotyktu (deucravacitinib) Data Show Consistent Safety and Durable Response Rates in Moderate-to-Severe Plaque Psoriasis

BMY

GuruFocus.com

8 days ago

BioArctic AB (BRCTF) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Profitability ...

BMY

MT Newswires

9 days ago

Bristol-Myers Squibb's Melanoma Treatment Fails to Meet Primary Endpoint in Phase 3 Adjuvant Trial

BMY

Business Wire

9 days ago

Bristol Myers Squibb Provides Update on Phase 3 RELATIVITY-098 Trial

Bristol-Myers Squibb Company (BMY) – Jim Cramer: “No, No, You Don’t Hold”
BMY

Insider Monkey

10 days ago

Bristol-Myers Squibb Company (BMY) – Jim Cramer: “No, No, You Don’t Hold”

Shareholders in Bristol-Myers Squibb (NYSE:BMY) have lost 7.2%, as stock drops 5.4% this past week
BMY

Simply Wall St.

10 days ago

Shareholders in Bristol-Myers Squibb (NYSE:BMY) have lost 7.2%, as stock drops 5.4% this past week

BMY Down 7% Post Q4 Earnings: Should You Buy, Sell or Hold the Stock?
BMY

Zacks

11 days ago

BMY Down 7% Post Q4 Earnings: Should You Buy, Sell or Hold the Stock?

Jim Cramer on Bristol-Myers (BMY): Cobenfy’s Success vs. Patent Headwinds
BMY

Insider Monkey

11 days ago

Jim Cramer on Bristol-Myers (BMY): Cobenfy’s Success vs. Patent Headwinds

BMS’ Phase II trial of CAR T cell therapy meets primary endpoint
BMY

Clinical Trials Arena

11 days ago

BMS’ Phase II trial of CAR T cell therapy meets primary endpoint

The Magnificent 7 Are So Last Year. Cash Cows Are the New Kings.
BMY

The Wall Street Journal

11 days ago

The Magnificent 7 Are So Last Year. Cash Cows Are the New Kings.

BMY

MT Newswires

12 days ago

Daiwa Securities Adjusts Bristol-Myers Squibb Price Target to $60 From $65, Maintains Outperform Rating

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
BMY

Zacks

12 days ago

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

Royalty Pharma Earnings: What To Look For From RPRX
BMY

StockStory

12 days ago

Royalty Pharma Earnings: What To Look For From RPRX

BMY

MT Newswires

12 days ago

Bristol-Myers Squibb Says Cancer Therapy Trial Meets Primary, Secondary Goals

BMY

MT Newswires

12 days ago

Deutsche Bank Adjusts Bristol-Myers Squibb Price Target to $53 From $55, Maintains Hold Rating

Bristol Myers Squibb Announces Positive Topline Results for Breyanzi® (lisocabtagene maraleucel) in Adult Patients with Relapsed or Refractory Marginal Zone Lymphoma
BMY

Business Wire

12 days ago

Bristol Myers Squibb Announces Positive Topline Results for Breyanzi® (lisocabtagene maraleucel) in Adult Patients with Relapsed or Refractory Marginal Zone Lymphoma

Jim Cramer on Bristol Myers (BMY): “Knocking It Out of the Park” – Is the Comeback Legit?
BMY

Insider Monkey

14 days ago

Jim Cramer on Bristol Myers (BMY): “Knocking It Out of the Park” – Is the Comeback Legit?

Bristol-Myers Squibb Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
BMY

Simply Wall St.

14 days ago

Bristol-Myers Squibb Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

BMY

MT Newswires

15 days ago

Leerink Partners Adjusts Price Target on Bristol-Myers Squibb to $68 From $73

BMY

MT Newswires

15 days ago

Wells Fargo Adjusts Price Target on Bristol-Myers Squibb to $62 From $60

BMY

MT Newswires

15 days ago

Morgan Stanley Adjusts Price Target on Bristol-Myers Squibb to $37 From $39

BMY

MT Newswires

15 days ago

Goldman Sachs Adjusts Price Target on Bristol-Myers Squibb to $67 From $65

Bristol-Myers Squibb Co (BMY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
BMY

GuruFocus.com

15 days ago

Bristol-Myers Squibb Co (BMY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

BMY

Thomson Reuters StreetEvents

16 days ago

Q4 2024 Bristol-Myers Squibb Co Earnings Call

BMY

Morningstar Research

16 days ago

Analyst Report: Bristol-Myers Squibb Company

Bristol-Myers Squibb stock in focus on weak outlook
BMY

Yahoo Finance Video

16 days ago

Bristol-Myers Squibb stock in focus on weak outlook

Bristol Myers Wallops Fourth-Quarter Views, But Shares Slide On 2025 Outlook
BMY

Investor's Business Daily

16 days ago

Bristol Myers Wallops Fourth-Quarter Views, But Shares Slide On 2025 Outlook

Bristol Myers Squibb (BMY) Q4 2024 Earnings Call Transcript
BMY

Motley Fool

16 days ago

Bristol Myers Squibb (BMY) Q4 2024 Earnings Call Transcript

Jim Cramer on Bristol-Myers Squibb (BMY): “First Schizophrenia Drug in 30 Years”
BMY

Insider Monkey

16 days ago

Jim Cramer on Bristol-Myers Squibb (BMY): “First Schizophrenia Drug in 30 Years”

Bristol Myers Squibb Warns Near-Term Impact Due To Generics On 2025 Sales Forecast, Outlines $2 Billion In Additional Cost Cuts
BMY

Benzinga

16 days ago

Bristol Myers Squibb Warns Near-Term Impact Due To Generics On 2025 Sales Forecast, Outlines $2 Billion In Additional Cost Cuts

Bristol Myers Earnings Are a ‘Tale of 2 Trends’ as Guidance Falls Short. The Stock Is Falling
BMY

Barrons.com

16 days ago

Bristol Myers Earnings Are a ‘Tale of 2 Trends’ as Guidance Falls Short. The Stock Is Falling

Bristol Myers Squibb (BMY) Beats Q4 Earnings and Revenue Estimates
BMY

Zacks

16 days ago

Bristol Myers Squibb (BMY) Beats Q4 Earnings and Revenue Estimates

Bristol-Myers Squibb (NYSE:BMY) Posts Better-Than-Expected Sales In Q4 But Full-Year Sales Guidance Misses Expectations
BMY

StockStory

16 days ago

Bristol-Myers Squibb (NYSE:BMY) Posts Better-Than-Expected Sales In Q4 But Full-Year Sales Guidance Misses Expectations

BMY

Investing.com

16 days ago

Bristol Myers misses expectations for 2025 guidance, shares fall

BMY

MT Newswires

16 days ago

Bristol-Myers Squibb's Q4 Non-GAAP Earnings Decline, Revenue Increases

BMY

Associated Press Finance

16 days ago

Bristol Myers: Q4 Earnings Snapshot

Pfizer beats Q4, FY '24 earnings estimates, stock flat in early trading
BMY

Yahoo Finance

18 days ago

Pfizer beats Q4, FY '24 earnings estimates, stock flat in early trading

BMY

MT Newswires

18 days ago

Cantor Fitzgerald Adjusts Bristol-Myers Squibb Price Target to $55 From $50, Maintains Neutral Rating

The Zacks Analyst Blog Highlights Merck, Pfizer, Eli Lilly, Amgen and Bristol Myers Squibb
BMY

Zacks

18 days ago

The Zacks Analyst Blog Highlights Merck, Pfizer, Eli Lilly, Amgen and Bristol Myers Squibb

BMY Gets Positive CHMP Opinion for Opdivo, Yervoy Combo and Breyanzi
BMY

Zacks

19 days ago

BMY Gets Positive CHMP Opinion for Opdivo, Yervoy Combo and Breyanzi

Jim Cramer on Bristol-Myers Squibb Company (BMY): ‘With That Yield, It’s One Of My Faves’
BMY

Insider Monkey

19 days ago

Jim Cramer on Bristol-Myers Squibb Company (BMY): ‘With That Yield, It’s One Of My Faves’

Should Bristol Myers Stock Be in Your Portfolio Pre-Q4 Earnings?
BMY

Zacks

19 days ago

Should Bristol Myers Stock Be in Your Portfolio Pre-Q4 Earnings?

Incyte (INCY) Earnings Expected to Grow: Should You Buy?
BMY

Zacks

19 days ago

Incyte (INCY) Earnings Expected to Grow: Should You Buy?

What Analyst Projections for Key Metrics Reveal About Bristol Myers (BMY) Q4 Earnings
BMY

Zacks

19 days ago

What Analyst Projections for Key Metrics Reveal About Bristol Myers (BMY) Q4 Earnings

2 High-Yield Dividend Stocks to Hold Through 2025 and Beyond
BMY

Motley Fool

19 days ago

2 High-Yield Dividend Stocks to Hold Through 2025 and Beyond

No One Knows How to Price AI Tools
BMY

The Wall Street Journal

21 days ago

No One Knows How to Price AI Tools

Why Bristol-Myers Squibb Company (BMY) Is Among the Best Long Term Low Risk Stocks to Buy Now
BMY

Insider Monkey

21 days ago

Why Bristol-Myers Squibb Company (BMY) Is Among the Best Long Term Low Risk Stocks to Buy Now

Top Dividend Stocks Yielding As High As 5%: Fidelity
BMY

Investor's Business Daily

22 days ago

Top Dividend Stocks Yielding As High As 5%: Fidelity

BMY

MT Newswires

22 days ago

Sector Update: Health Care Stocks Gain in Early Morning Trading Friday

Why Investors Need to Take Advantage of These 2 Medical Stocks Now
BMY

Zacks

22 days ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

BMY

MT Newswires

22 days ago

Bristol-Myers Squibb Says EU Regulator Panel Recommends Liver Cancer Treatment for Approval

BMY

MT Newswires

22 days ago

Bristol-Myers Squibb Says EU Panel Recommends Breyanzi's Approval for Follicular Lymphoma

Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment Option for Adult Patients with Unresectable or Advanced Hepatocellular Carcinoma
BMY

Business Wire

22 days ago

Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment Option for Adult Patients with Unresectable or Advanced Hepatocellular Carcinoma

Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma
BMY

Business Wire

22 days ago

Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma

Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?
BMY

Zacks

23 days ago

Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?

Bristol Myers Squibb (BMY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
BMY

Zacks

23 days ago

Bristol Myers Squibb (BMY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
BMY

Zacks

23 days ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Why Bristol-Myers Squibb Company (BMY) Is the Best Blue Chip Stock to Buy Under $100?
BMY

Insider Monkey

24 days ago

Why Bristol-Myers Squibb Company (BMY) Is the Best Blue Chip Stock to Buy Under $100?

Bristol-Myers Squibb (BMY): Cramer’s Old-School Move for DeepSeek Market Jitters
BMY

Insider Monkey

24 days ago

Bristol-Myers Squibb (BMY): Cramer’s Old-School Move for DeepSeek Market Jitters

Bristol-Myers Squibb Insider Ups Holding During Year
BMY

Simply Wall St.

24 days ago

Bristol-Myers Squibb Insider Ups Holding During Year

3 Cheap Dividend Stocks That Pay More Than Double the S&P 500 Average
BMY

Motley Fool

24 days ago

3 Cheap Dividend Stocks That Pay More Than Double the S&P 500 Average

Is Bristol-Myers Squibb Company (BMY) the Safe Stock to Buy for the Long Term in 2025?
BMY

Insider Monkey

24 days ago

Is Bristol-Myers Squibb Company (BMY) the Safe Stock to Buy for the Long Term in 2025?

Drugmakers Show Restraint on Price Increases in New Trump Era
BMY

The Wall Street Journal

25 days ago

Drugmakers Show Restraint on Price Increases in New Trump Era

BMY

MT Newswires

25 days ago

Citigroup Adjusts Price Target on Bristol-Myers Squibb to $65 From $60, Keeps Neutral Rating

Why the Market Dipped But Bristol Myers Squibb (BMY) Gained Today
BMY

Zacks

a month ago

Why the Market Dipped But Bristol Myers Squibb (BMY) Gained Today

BMY

MT Newswires

a month ago

TD Cowen Adjusts Price Target on Bristol-Myers Squibb to $64 From $59

Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know
BMY

Zacks

a month ago

Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know

Bristol Myers Squibb Presents Results from CheckMate -8HW Analysis Evaluating Opdivo® (nivolumab) plus Yervoy® (ipilimumab) Compared to Opdivo Monotherapy...
BMY

Business Wire

a month ago

Bristol Myers Squibb Presents Results from CheckMate -8HW Analysis Evaluating Opdivo® (nivolumab) plus Yervoy® (ipilimumab) Compared to Opdivo Monotherapy...

Is Bristol-Myers Squibb Company (BMY) the Best Stock to Invest In For Steady Dividends?
BMY

Insider Monkey

a month ago

Is Bristol-Myers Squibb Company (BMY) the Best Stock to Invest In For Steady Dividends?

Jim Cramer Says Bristol-Myers Squibb Company (BMY)’s ‘Got The One That Everybody Is Buzzing About’
BMY

Insider Monkey

a month ago

Jim Cramer Says Bristol-Myers Squibb Company (BMY)’s ‘Got The One That Everybody Is Buzzing About’

Why Is Bristol-Myers Squibb Company (BMY) Among the Best High-Yield Dividend Stocks to Invest In?
BMY

Insider Monkey

a month ago

Why Is Bristol-Myers Squibb Company (BMY) Among the Best High-Yield Dividend Stocks to Invest In?

Bristol-Myers Squibb Company (NYSE:BMY) is largely controlled by institutional shareholders who own 77% of the company
BMY

Simply Wall St.

a month ago

Bristol-Myers Squibb Company (NYSE:BMY) is largely controlled by institutional shareholders who own 77% of the company

Bristol-Myers Squibb Company (BMY): A Bull Case Theory
BMY

Insider Monkey

a month ago

Bristol-Myers Squibb Company (BMY): A Bull Case Theory

Why Bristol-Myers Squibb (BMY) Is One of the Best Cheap Stocks to Buy for 2025?
BMY

Insider Monkey

a month ago

Why Bristol-Myers Squibb (BMY) Is One of the Best Cheap Stocks to Buy for 2025?

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
BMY

TipRanks

a month ago

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

Bristol Myers Squibb (BMY) Stock Dips While Market Gains: Key Facts
BMY

Zacks

a month ago

Bristol Myers Squibb (BMY) Stock Dips While Market Gains: Key Facts

BMY

MT Newswires

a month ago

Update: Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks

Ozempic Among the Next Drugs Up for Medicare Price Negotiations
BMY

The Wall Street Journal

a month ago

Ozempic Among the Next Drugs Up for Medicare Price Negotiations

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations
BMY

Yahoo Finance

a month ago

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations

Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock
BMY

Zacks

a month ago

Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock

BMY

MT Newswires

a month ago

Bristol-Myers Squibb Company Exercises Exclusive License Option for ArsenalBio's AB-4000 Series

ArsenalBio and Bristol Myers Squibb Achieve Milestone for AB-4000 Series as Part of Ongoing Multi-Program Collaboration to Advance Next-Generation T Cell Therapies for Solid Tumors
BMY

GlobeNewswire

a month ago

ArsenalBio and Bristol Myers Squibb Achieve Milestone for AB-4000 Series as Part of Ongoing Multi-Program Collaboration to Advance Next-Generation T Cell Therapies for Solid Tumors

AI, vaccine distrust, & the future of healthcare: Novartis CEO
BMY

Yahoo Finance Video

a month ago

AI, vaccine distrust, & the future of healthcare: Novartis CEO

BMY

MT Newswires

a month ago

Redburn Atlantic Adjusts Price Target on Bristol-Myers Squibb to $52 From $53, Maintains Neutral Rating

Bristol Myers Squibb (BMY) Stock Slides as Market Rises: Facts to Know Before You Trade
BMY

Zacks

a month ago

Bristol Myers Squibb (BMY) Stock Slides as Market Rises: Facts to Know Before You Trade

How To Put $100 In Your Retirement Fund Each Month With Bristol-Myers Squibb Stock
BMY

Benzinga

a month ago

How To Put $100 In Your Retirement Fund Each Month With Bristol-Myers Squibb Stock

J&J Pauses Sales of Atrial Fibrillation Device, Stock Down
BMY

Zacks

a month ago

J&J Pauses Sales of Atrial Fibrillation Device, Stock Down

This Unpopular Dividend Stock Is a Buy
BMY

Motley Fool

a month ago

This Unpopular Dividend Stock Is a Buy

Bristol Myers Stock Gains 11.4% in a Year: Time to Buy or Sell?
BMY

Zacks

a month ago

Bristol Myers Stock Gains 11.4% in a Year: Time to Buy or Sell?

Share on Social Networks: